Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Letter to Shareholders
Newsletters
Q & A
Financial documents
General Shareholders’ meetings
Regulated information
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Our videos
Agenda
Press Releases
Contact
en
fr
Projects Archives
September 2024
Word Conference on Lung Cancer (WCLC)
January 2024
BIO-EUROPE Spring®
January 2024
Symposium on Resolution of Inflammation in Medicine and Surgery, Harvard Medical School
January 2024
KEYSTONE SYMPOSIA on Molecular and Cellular Biology
January 2024
Paris European “Midcap Event”©
January 2024
Spring European “Midcap Event”©
January 2024
Paris European “Small & Midcap Event”©
January 2024
European “Midcap Event”©
January 2024
JPM HEALTHCARE CONFERENCE
December 2023
INVEST SECURITIES BIOMED FORUM 2024
Précédent
1
2
3
4
5
Suivant